Envestnet Asset Management
LYRA

Envestnet Asset Management’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Envestnet Asset Management’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-736
Closed -$426K – 3672
2021
Q1 		$426K Buy
+736
New +$460K ﹤0.01% 2939

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Envestnet Asset Management's LYRA Position: Q2 2021 in Review

Envestnet Asset Management sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2021, closing a stake of 736 shares — an estimated $426K sold.

Envestnet Asset Management first reported a position in LYRA in Q1 2021 and held it in 1 quarter. The position peaked at $426K in Q1 2021. 44 funds tracked by Wall St. Rank hold LYRA as of Q2 2021.

  • Envestnet Asset Management reported no remaining LYRA THERAPEUTICS INC position as of Q2 2021 after selling out during the quarter.
  • Envestnet Asset Management sold 736 LYRA THERAPEUTICS INC shares in Q2 2021, an estimated $426K.
  • Envestnet Asset Management first reported a position in LYRA THERAPEUTICS INC in Q1 2021 and held it in 1 quarter.
  • Envestnet Asset Management's LYRA THERAPEUTICS INC position peaked at $426K in Q1 2021.
  • 44 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2021.

Based on Envestnet Asset Management's 13F filing for Q2 2021, filed 4 Aug 2021.